| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/29/2011 | WO2011116797A1 Kit for detection of human papillomavirus |
| 09/29/2011 | WO2011116497A1 Compositions and methods for the rapid detection of legionella pneumophila |
| 09/29/2011 | WO2011116481A1 Sample collection tool |
| 09/29/2011 | WO2011116466A1 Dna polymorphisms as molecular markers in cattle |
| 09/29/2011 | WO2011116456A1 Methods and compositions for the detection and identification of archaea based on the type ii chaperonin (thermosome) gene |
| 09/29/2011 | WO2011116432A1 Methods and compositions for detecting banned substances |
| 09/29/2011 | WO2011097644A3 Selective reduction of allelic variants |
| 09/29/2011 | WO2011097503A3 Method to detect repeat sequence motifs in nucleic acid |
| 09/29/2011 | WO2011086161A3 Biomarkers of ageing |
| 09/29/2011 | WO2011084619A3 Elimination of pathogenic infection in farmed animal populations |
| 09/29/2011 | WO2011065982A3 Polymorphisms associated with parkinson's disease |
| 09/29/2011 | WO2011062933A3 Array-based proximity ligation association assays |
| 09/29/2011 | WO2011057197A3 Integrated droplet actuator for gel electrophoresis and molecular analysis |
| 09/29/2011 | WO2011057107A3 Microchamber electrochemical cell having a nanoslot |
| 09/29/2011 | WO2011053894A3 Methods and apparatus for binding assays |
| 09/29/2011 | WO2011053871A3 Multi-primer assay for mycoplasma detection |
| 09/29/2011 | WO2011053825A3 Compositions and methods for the treatment or prevention of mitochondrial diseases |
| 09/29/2011 | WO2011050379A9 Use of gstp1 |
| 09/29/2011 | WO2011050134A3 Detection and treatment of lrp4-associated neurotransmission disorders |
| 09/29/2011 | WO2011043823A3 Polypeptides that home to atherosclerotic plaque |
| 09/29/2011 | WO2011039359A3 Authentication method of dairy products |
| 09/29/2011 | WO2011035185A3 A microfluidic device and uses thereof |
| 09/29/2011 | WO2011034953A3 Lassa virus-like particles and methods of production thereof |
| 09/29/2011 | WO2011029034A3 Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci |
| 09/29/2011 | WO2010126370A3 Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure |
| 09/29/2011 | US20110239333 Polypeptides Having Xylanase Activity And Polynucleotides Thereof |
| 09/29/2011 | US20110239326 Hybrid-type histidine kinase gene isolated from indica rice ir64 |
| 09/29/2011 | US20110239321 Herbicide tolerant soybean plants and methods for identifying same |
| 09/29/2011 | US20110239319 Use of Endonucleases for Inserting Transgenes Into Safe Harbor Loci |
| 09/29/2011 | US20110239312 Methods of diagnosing and treating motor neuron diseases |
| 09/29/2011 | US20110239311 Agonists of NR2F6 For Immunosupression |
| 09/29/2011 | US20110237655 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 09/29/2011 | US20110237644 Ubiquitin specific proteases responsible for mcl-1 stability and uses thereof |
| 09/29/2011 | US20110237643 Identification of a Novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity |
| 09/29/2011 | US20110237631 Selective Glycosidase Inhibitors and Uses Thereof |
| 09/29/2011 | US20110237560 Modulating and/or detecting activation induced deaminase and methods of use thereof |
| 09/29/2011 | US20110237540 Cyclodextrin-based polymers for therapeutic delivery |
| 09/29/2011 | US20110237537 Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis |
| 09/29/2011 | US20110237535 Use of Induced Pluripotent Cells and other Cells for Screening Compound Libraries |
| 09/29/2011 | US20110237518 Method for treating or preventing bladder cancer using the depdc1 polypeptide |
| 09/29/2011 | US20110237501 Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1 |
| 09/29/2011 | US20110237485 Chrysosporium Cellulase and Methods of Use |
| 09/29/2011 | US20110237459 Multiplexed Assay Using Encoded Solid Support Matrices |
| 09/29/2011 | US20110237458 Drug discovery method |
| 09/29/2011 | US20110237457 Method and system of particle-coupled phage epitope |
| 09/29/2011 | US20110237456 Biomarkers for drug-induced elongated qt interval and torsades de pointes |
| 09/29/2011 | US20110237454 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same |
| 09/29/2011 | US20110237453 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same |
| 09/29/2011 | US20110237452 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same |
| 09/29/2011 | US20110237451 Competitive n-hybrid system |
| 09/29/2011 | US20110237450 Methods and systems of using exosomes for determining phenotypes |
| 09/29/2011 | US20110237447 Method of determining chromatin structure |
| 09/29/2011 | US20110237444 Methods of mapping genomic methylation patterns |
| 09/29/2011 | US20110237443 Amelogenin SNP on Chromosome X |
| 09/29/2011 | US20110236924 System and method for processing samples |
| 09/29/2011 | US20110236923 Method for staining and sorting of a small volume of sperm |
| 09/29/2011 | US20110236922 Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium |
| 09/29/2011 | US20110236921 Cell system |
| 09/29/2011 | US20110236920 Novel variants of pqq-dependent glucose dehydrogenase having improved substrate specificity |
| 09/29/2011 | US20110236919 Process for restricting carbon monoxide dissolution in a syngas fermentation |
| 09/29/2011 | US20110236918 Methods for conducting genetic analysis using protein polymorphisms |
| 09/29/2011 | US20110236917 Diagnosis of Alzheimer's Disease |
| 09/29/2011 | US20110236916 Methods and materials for detecting colorectal neoplasm |
| 09/29/2011 | US20110236915 Zap-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (cll/sll) |
| 09/29/2011 | US20110236913 Compostion and kit for diagnosing immunoglobulin a nephropathy and tgbm nephropathy |
| 09/29/2011 | US20110236909 Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors |
| 09/29/2011 | US20110236908 Total plasma fvii/fviia levels as indicators of pre-eclampsia of pregnant females |
| 09/29/2011 | US20110236906 Secretory protein biomarkers for high efficiency protein expression |
| 09/29/2011 | US20110236905 Method for screening cattle, cattle screened, and cattle screening kit |
| 09/29/2011 | US20110236903 Materials and methods for determining diagnosis and prognosis of prostate cancer |
| 09/29/2011 | US20110236902 Testing a patient population having a cardiovascular condition for drug efficacy |
| 09/29/2011 | US20110236901 Thermal cycling system comprising transport heater |
| 09/29/2011 | US20110236900 Novel muts protein and method for determing mutation using the same |
| 09/29/2011 | US20110236899 Method and Apparatus for Predicting Pharmaceutical Efficacy of Anti-TNFa Antibody Drug Against Rheumatoid Arthritis |
| 09/29/2011 | US20110236898 Methods for enhancing nucleic acid hybridization |
| 09/29/2011 | US20110236897 Novel markers for diagnosing brain disease caused by brain injury and use thereof |
| 09/29/2011 | US20110236896 Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication |
| 09/29/2011 | US20110236895 Method for preparing sample, solution for preparing sample and stool collection kit method for analyzing a nucleic acid |
| 09/29/2011 | US20110236894 Selective oxidation of 5-methylcytosine by tet-family proteins |
| 09/29/2011 | US20110236893 Lgr5 modulators in the treatment of alopecia |
| 09/29/2011 | US20110236892 Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay |
| 09/29/2011 | US20110236891 Nucleic acid template preparation for real-time pcr |
| 09/29/2011 | US20110236890 Method of screening for cancer by detecting mutations in the delta-catenin gene promoter and 5'-untranslated region |
| 09/29/2011 | US20110236889 Methods of screening for compounds for use as modulators of left-right asymmetry in scoliotic subjects and for monitoring efficacy of an orthopaedic device |
| 09/29/2011 | US20110236888 Method for accessing the contents of a closed vessel containing a specimen retrieval device |
| 09/29/2011 | US20110236887 Modified actinomycin-based nucleic acid stains and methods of their use |
| 09/29/2011 | US20110236886 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination |
| 09/29/2011 | US20110236885 Genetic Variants Predicting Warfarin Sensitivity |
| 09/29/2011 | US20110236884 Microbubbles for affinity separation |
| 09/29/2011 | US20110236883 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification |
| 09/29/2011 | US20110236882 Quantitative measurement of nano/micro particle endocytosis with cell mass spectrometry |
| 09/29/2011 | US20110236881 Modulation of influenza virus |
| 09/29/2011 | US20110236880 Potentiated Biocidal Compositions and Methods of Use |
| 09/29/2011 | US20110236879 Methods and compositions for analyte detection |
| 09/29/2011 | US20110236878 Rapid Characterization of Proteins in Complex Biological Fluids |
| 09/29/2011 | US20110236877 Biosensor and method using the same to perform a biotest |
| 09/29/2011 | US20110236874 Method for formation of renal tubules |
| 09/29/2011 | US20110236507 Inhibition of dna polymerases to augment chemotherapeutic and antimicrobial agents |
| 09/29/2011 | US20110236427 Antagonists of NR2F6 For Augmenting The Immune Response |
| 09/29/2011 | US20110236422 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |